51.42 0.00 (0.00%)
After hours: 4:54PM EDT
|Bid||50.50 x 1300|
|Ask||51.45 x 1100|
|Day's range||50.95 - 52.81|
|52-week range||33.71 - 67.08|
|PE ratio (TTM)||32.71|
|Earnings date||19 Nov 2018 - 23 Nov 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||58.38|
The Dow Jones Industrial Average held onto its gains to notch a fresh high, but the S&P 500 and Nasdaq fell into the red as Friday drew to a close
The company ended the fiscal year with strong results, but increased expenses due to Hurricane Harvey hurt full-year earnings.
European Union regulators opens in-depth probe to find out whether there is a possible collusion between top automakers to delay the development of emission technologies.
Stocks that moved substantially or traded heavily on Wednesday: AutoNation Inc., up 82 cents to $43.91 CEO Mike Jackson is departing after almost two decades leading the nation's largest auto dealership ...
Copart earnings missed views, sending shares of the online car auction company sharply lower Wednesday. Copart stock triggered three notable sell signals.
The Dow Jones industrials led the stock market up. Cannabis play Tilray has made an almost vertical move up, suggesting that the monthlong rally is showing signs of overheating.
The Dow led mixed stock market action early Wednesday. IBD 50 stock Copart skidded to a sell signal on weak earnings.
Get timely chart analysis and investing lessons on leading stocks that have earned a spot on the IBD 50, an S&P 500-beating screen featuring today's best growth stocks.
Copart (CPRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With a market capitalization of US$14.57b, Copart Inc (NASDAQ:CPRT) is a large-cap stock, which is considered by most investors as a safe bet. Common characteristics for these big stocks areRead More...
Five top stocks with IBD Composite Ratings of 95 or higher are closing in on buy points: Urban Outfitters, Veeva Systems, Copart, Automatic Data Processing and Jazz Pharmaceuticals.
The stock indexes gapped down Friday in a decline that broke with the pattern of mild price moves over the past couple of weeks.
The $1.3 billion Oppenheimer Discovery Mid Cap Growth Fund is outperforming this year. It's doing that with stock diversification.
NEW YORK, Aug. 10, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Retail ...
In a discussion of the best growth stocks, IBD 50 component Copart isn't the first company that comes to mind. But it definitely deserves a spot in the conversation.
Baozun and Wildhorse Resource were early leaders among IBD 50 stocks Tuesday. NetEase jumped on an analyst upgrade, and Copart jumped into its first session on the S&P 500 index.